Cardlytics Inc
$ 0.87
1.60%
24 Feb - close price
- Market Cap 46,202,100 USD
- Current Price $ 0.87
- High / Low $ 0.93 / 0.85
- Stock P/E N/A
- Book Value -0.09
- EPS -2.06
- Next Earning Report 2026-03-11
- Dividend Per Share N/A
- Dividend Yield 0 %
- Next Dividend Date -
- ROA -0.09 %
- ROE -3.41 %
- 52 Week High 3.28
- 52 Week Low 0.80
About
Cardlytics, Inc. operates an advertising platform within financial institutions' digital channels including online, mobile, email, and various real-time notifications in the United States and the United Kingdom. The company is headquartered in Atlanta, Georgia.
Analyst Target Price
$1.62
Quarterly Earnings
| Sep 2025 | Jun 2025 | Mar 2025 | Dec 2024 | Sep 2024 | Jun 2024 | Mar 2024 | Dec 2023 | Sep 2023 | Jun 2023 | Mar 2023 | Dec 2022 | |
|---|---|---|---|---|---|---|---|---|---|---|---|---|
| Reported Date | 2025-11-04 | 2025-07-28 | 2025-04-30 | 2025-03-12 | 2024-11-06 | 2024-08-07 | 2024-05-08 | 2024-03-14 | 2023-11-08 | 2023-08-01 | 2023-05-04 | 2023-03-01 |
| Reported EPS | -0.07 | -0.13 | -0.21 | -0.31 | -0.15 | -0.15 | -0.09 | 0.14 | 0.01 | -0.24 | -0.25 | -0.29 |
| Estimated EPS | -0.3467 | -0.39 | -0.2667 | -0.47 | -0.24 | -0.13 | -0.11 | 0.12 | -0.01 | -0.35 | -0.56 | -0.46 |
| Surprise | 0.2767 | 0.26 | 0.0567 | 0.16 | 0.09 | -0.02 | 0.02 | 0.02 | 0.02 | 0.11 | 0.31 | 0.17 |
| Surprise Percentage | 79.8096% | 66.6667% | 21.2598% | 34.0426% | 37.5% | -15.3846% | 18.1818% | 16.6667% | 200% | 31.4286% | 55.3571% | 36.9565% |
Next Quarterly Earnings
| Dec 2025 | |
|---|---|
| Reported Date | 2026-03-11 |
| Fiscal Date Ending | 2025-12-31 |
| Estimated EPS | |
| Currency | USD |
Next Dividend Records
| Dividend per share (year): | - |
| Dividend Yield | - |
| Next Dividend Date | - |
| Ex-Dividend Date | - |
Recent News: CDLX
2026-02-20 03:28:42
Cardlytics (NASDAQ: CDLX) announced that its financial results for the fourth quarter and full year ending December 31, 2025, will be released after market close on March 4, 2026. The company will host a conference call on the same day at 5:00 pm Eastern time to discuss the results, with details provided for webcast and dial-in access. Cardlytics is a commerce media platform utilizing first-party purchase data to connect advertisers and publishers with consumers.
2026-02-19 21:07:08
Cardlytics, Inc. (NASDAQ: CDLX) announced that its financial results for the fourth quarter and full year ending December 31, 2025, will be released on March 4, 2026, after market close. The company will host a conference call and webcast on the same day at 5:00 pm Eastern time to discuss the results. Individuals can access the live audio webcast via the Cardlytics Investor Relations website or by registering through a provided link, with a replay available afterward.
2026-02-19 20:57:31
Cardlytics, Inc. (NASDAQ: CDLX) will release its financial results for the fourth quarter and full year ending December 31, 2025, on March 4, 2026, after market close. Investors can access the live audio webcast on the Cardlytics Investor Relations website or by registering through a provided link. A replay of the call will be available on the website afterward.
2026-02-18 21:57:08
Cardlytics (NASDAQ:CDLX) CEO Amit Gupta recently sold 45,159 shares of the company's stock for approximately $41,998, reducing his stake by 6.41%. This sale occurred on February 18th at an average price of $0.93 per share, following other sales earlier in February and January. Cardlytics currently trades around $0.93 with a market cap of $50.3 million and carries an average analyst rating of "Reduce" with a $2.25 price target.
2026-01-27 20:58:08
Craig-Hallum has reiterated its Hold rating on Cardlytics (CDLX.US). This indicates that the firm advises investors to maintain their current positions in the stock without buying or selling.
2026-01-27 20:58:08
Needham analyst Kyle Peterson maintained a Hold rating on Cardlytics (CDLX) following the company's divestiture of its Bridg business. Peterson views the sale as a prudent strategic move to bolster liquidity and refocus on core operations, despite the loss incurred compared to its original acquisition price. However, concerns over Cardlytics' fragile balance sheet and liquidity prevent an upgrade to a Buy rating, as the company needs to demonstrate a more durable capital structure before supporting significant growth.
